echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > What should I do if I have hepatitis B?

    What should I do if I have hepatitis B?

    • Last Update: 2021-05-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Source: Economic Daily-China Economic Net

    According to statistics, there are about 70 million cases of hepatitis B virus carriers in my country, including about 20 million to 30 million cases of chronic hepatitis B patients.


    What are the ways of transmission of hepatitis B

    What are the ways of transmission of hepatitis B

    Chronic hepatitis B is a chronic inflammatory disease of the liver caused by chronic hepatitis B virus (HBV) persistent infection.


    In my country, mother-to-child transmission is the main mode of transmission of chronic hepatitis B, accounting for 30% to 50%.


    HBV does not spread through the respiratory and digestive tracts.


    How to prevent hepatitis B

    How to prevent hepatitis B

    Protect susceptible people.


    Manage the source of infection.


    Cut off the route of transmission.


    How to treat hepatitis B

    How to treat hepatitis B

    For hepatitis B, there is currently no cure, but drugs can control virus replication, delay the progression of the disease, improve the quality of life of patients, and prolong their survival time.


    During hepatitis B treatment, the medication cycle is longer, generally at least 2 to 3 years, or even for life.


    Tenofovir, a traditional treatment for hepatitis B, can cause gastrointestinal reactions, osteoporosis, and renal tubular damage.


    At the 2021 Asia-Pacific Association of Liver Diseases Annual Meeting (2021APASL), researchers from Southern Medical University Nanfang Hospital and Hausen Pharmaceuticals (the main body of Hansen Pharmaceuticals) jointly published a large-scale phase III clinical study of the drug in Chinese patients with chronic hepatitis B 48 weeks results.


    Considering that patients with hepatitis B need long-term medication, imitenofovir can help patients with hepatitis B reduce the side effects of the drug while achieving a curative effect equivalent to that of tenofovir disoproxil (TDF).


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.